TL;DR
- Palantir's patient data tech rejected by many NHS trusts in England
- Health bodies cite lack of improvement over existing systems
Summary
A recent analysis reveals that Palantir's patient data platform has failed to gain significant traction among NHS trusts in England. Despite its widespread adoption in other sectors, the US-based firm's technology has been met with skepticism by health bodies across the country. According to the original piece, many NHS trusts have rejected Palantir's platform, citing its inability to offer any significant improvements over existing systems.
Content
The reporting details a concerning trend in the UK's National Health Service (NHS) England, where Palantir's patient data platform has been met with resistance from health bodies. The US-based firm's technology, touted as a game-changer in the healthcare sector, has failed to deliver on its promises. According to the original piece, many NHS trusts have opted to stick with their existing systems, citing concerns over data security, interoperability, and overall effectiveness. This raises important questions about the role of private sector firms in the NHS and the need for more robust evaluation of new technologies before adoption. As the NHS continues to grapple with the challenges of data-driven healthcare, it is clear that more needs to be done to ensure that patients receive the best possible care. The implications of Palantir's failed rollout are far-reaching, highlighting the need for greater transparency and accountability in the procurement process.
ICYMI
- Palantir's patient data platform has been rejected by many NHS trusts in England due to concerns over data security and interoperability.
- The NHS has opted to stick with existing systems, citing their effectiveness and familiarity.
- The failed rollout of Palantir's platform raises important questions about the role of private sector firms in the NHS and the need for more robust evaluation of new technologies.
Original Post is from: The Guardian
Read it here
See this article here: